September 2010 - Volume 52 - Issue 3 : Hepatology

Secondary Logo

Journal Logo

September 2010 - Volume 52 - Issue 3
pp: 807-1176


Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection†

Muir, Andrew J.; Shiffman, Mitchell L.; Zaman, Atif; More

Hepatology. 52(3):822-832, September 2010.

Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C†,‡,§,¶

Morgan, Timothy R.; Ghany, Marc G.; Kim, Hae-Young; More

Hepatology. 52(3):833-844, September 2010.

Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy†,‡

Harrison, Stephen A.; Rossaro, Lorenzo; Hu, Ke-Qin; More

Hepatology. 52(3):864-874, September 2010.

Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡

Chang, Ting-Tsung; Liaw, Yun-Fan; Wu, Shun-Sheng; More

Hepatology. 52(3):886-893, September 2010.


Clinical, Laboratory and Histological Associations in Adults with Nonalcoholic Fatty Liver Disease†

Neuschwander-Tetri, Brent A.; Clark, Jeanne M.; Bass, Nathan M.; More

Hepatology. 52(3):913-924, September 2010.

HFECys282Tyr Homozygotes With Serum Ferritin Concentrations Below 1000 μg/L Are at Low Risk of Hemochromatosis†,‡

Allen, Katrina J.; Bertalli, Nadine A.; Osborne, Nicholas J.; More

Hepatology. 52(3):925-933, September 2010.

High-Fructose, Medium Chain Trans Fat Diet Induces Liver Fibrosis and Elevates Plasma Coenzyme Q9 in a Novel Murine Model of Obesity and Nonalcoholic Steatohepatitis†

Kohli, Rohit; Kirby, Michelle; Xanthakos, Stavra A.; More

Hepatology. 52(3):934-944, September 2010.



Show:
  NODES
Association 4
Note 1